Plexiform neurofibroma causing an ossifying subperiosteal haematoma: a rare case in the tibia of an 11-year-old girl

Subperiosteal hematoma as a rare complication of neurofibromatosis 1: A case report and review of the literature

INTRODUCTION

Subperiosteal hematoma (SPH) is a rare complication of neurofibromatosis type 1 (NF-1) which can be presented spontaneously or after a minor trauma a painful or painless growing lesion.

PRESENTATION OF CASE

Here, we presented a 10-year-old boy, a known case of NF-1, who presented with a painless growing leg lesion. The bony wall cystic lesion was suggested based on radiologic and pathologic investigation. During the operation, an SPH was detected and excised completely.

DISCUSSION

Consistent with previous reports, our case of subperiosteal hematoma in an NF-1 patient predominantly presented with well-established subperiosteal bone proliferation on plain radiographs, with the hematoma most commonly affecting the tibia.

CONCLUSION

The SPH in NF-1 and differentiating it from a malignant transformation should be considered for the rapidly enlarging bony mass.

Rapid Forehead Ossification due to a Subperiosteal Hematoma in a Patient With Neurofibromatosis Type 1

Rapid ossification due to a subperiosteal hematoma in extremities has occasionally been documented in patients with neurofibromatosis type 1, but it has not been reported in the maxillofacial region. The authors present the first case of a subperiosteal hematoma in the forehead. A 36-year-old man presented with a rapidly swelling firm, fixed, 8×10 cm forehead mass. It became evident shortly after a fine-needle aspiration biopsy. Computed tomography imaging 2 months after the biopsy showed a hematoma that was encapsulated by a surrounding layer of ossification. Magnetic resonance imaging displayed a fluid-fluid level under the ossified area. These characteristic images led us to diagnose this rare lesion as a subperiosteal hematoma with ossification. Rapid ossification is a characteristic imaging finding of subperiosteal hematoma, which makes definitive diagnosis easy. It becomes imperative to underscore the potential risks of fine-needle aspiration in proximity to the periosteum in patients with neurofibromatosis type 1.

Report of a Rare Case of Beta-Thalassemia Major With Subperiosteal Hematomas

Beta-thalassemia represents a range of hemoglobinopathies that are a consequence of an impairment in the synthesis of beta-globin chains. They result in different degrees of hemolysis and ineffective erythropoiesis, depending on the underlying mutations. They can lead to severe complications mainly resulting from anemia. However, there is no bleeding tendency in this disorder, and it is uncommon to see hematoma formation in affected patients.

To our knowledge, subperiosteal hematomas have been rarely described in the context of beta-thalassemia. Herein, we report a unique case of a 19-year-old boy who was diagnosed with transfusion-dependent beta-thalassemia and secondary hemochromatosis and developed atraumatic subperiosteal hematomas along the humerus.

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey

BACKGROUND/AIM

Neurofibromatosis type 1 (NF) is an autosomal dominant hereditary disease. The cardinal clinical findings include characteristic skeletal alterations. Difficulties in diagnosis and therapy can arise if an individual has further illnesses.

CASE REPORT

This is a case report of a 16-year-old patient affected by NF1. She also suffered from Alagille syndrome and the consequences of fetal alcohol exposure. The patient's facial phenotype showed findings that could be assigned to one or more of the known diseases. The patient was referred for treating a cherubism-like recurrent central giant cell granuloma (CGCG) of the jaw. The patient developed bilateral, multilocular non-ossifying fibromas (NOF) of the long bones of the lower extremity. Treatment of the skeletal lesions consisted of local curettage. While NOF regressed after surgery, the CGCG of the jaw remained largely unchanged. Extensive genetic tests confirmed a previously unknown germline mutation in the JAG1 gene, the germline mutation of the NF1 gene, and the somatic mutation in the NF1 gene in the diffuse plexiform neurofibroma, but not in the CGCG.

CONCLUSION

Assigning facial findings to a defined syndrome is ambiguous in many cases and especially difficult in patients who have multiple diseases that can affect the facial phenotype. Surgical therapy should be adapted to the individual findings.

Ossifying Subperiosteal Hematoma Caused by a Plexiform Neurofibroma

Teaching Point: Subperiosteal haemorrhage is a rare complication of a plexiform neurofibroma which may mimic a malignant peripheral nerve sheath tumour.

Subperiosteal hemorrhage: A rare complication in neurofibromatosis which may mimic malignant peripheral nerve sheath tumor

Currently, there is little in the medical literature on subperiosteal hematomas in neurofibromatosis patients, particularly in those who have subperiosteal neurofibromas. Initial imaging and clinical presentation can be very worrisome and to the unaware may lead to early surgical intervention and/or anxiety in the patient and parents. This report presents the case of a 9-year-old child with neurofibromatosis type-1 and progressively increasing calf pain and swelling about a known plexiform neurofibroma. Imaging at initial presentation and at 1 month demonstrated evolving subperiosteal hemorrhage. This report adds to the small body of literature on subperiosteal hemorrhage as a complication of neurofibromatosis. Additionally, this report demonstrates an approach to noninvasive management of these lesions with the utility of initial and 1 month follow-up radiographs helpful in demonstrating hemorrhage evolution and possibly negating the need for biopsy.